EMERGENT BIOSOLUTIONS INC.

EBS US29089Q1058

🆔
Registration No.
3736090
💰
Capitalization
Small-cap

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

🏢
Founded
2014
Annual Performance 1
2021 2022 2023 2024 2025
-53% -75% -80% 269% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
14
🙍
Insiders
7
Person Price Shares Total Published Completed
Zoon Kathryn C
8.87
USD
7,086
Sold
62,853
USD
15/08/2025 15/08/2025
Degolyer Donald W
8.65
USD
7,844
Sold
67,831
USD
12/08/2025 12/08/2025
Katkin Keith
6.30
USD
7,844
Sold
49,417
USD
23/05/2025 23/05/2025
Katkin Keith
6.30
USD
7,844
Sold
49,417
USD
23/05/2025 23/05/2025
Papa Joseph C
CEO
5.83
USD
60,000
Bought
349,800
USD
13/05/2025 13/05/2025
Papa Joseph C
CEO
5.83
USD
60,000
Bought
349,800
USD
13/05/2025 13/05/2025
Fowler Neal Franklin
5.83
USD
35,000
Sold
204,050
USD
12/03/2025 12/03/2025
Zoon Kathryn C
5.73
USD
10,000
Sold
57,300
USD
12/03/2025 12/03/2025
Degolyer Donald W
10.91
USD
25,000
Sold
272,750
USD
12/11/2024 12/11/2024
White Marvin L
11.97
USD
14,287
Sold
171,015
USD
11/11/2024 11/11/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include EMERGENT BIOSOLUTIONS INC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
1% -26% 316% 7% -89% -72% -87%
Last 52W Low 52W High All-Time Low All-Time High β
9.14 4.26 9.32 4.26 9.32
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Papa Joseph C 2 699,600.00 349,800.00 13/05/2025 13/05/2025
Degolyer Donald W 2 340,580.99 170,290.49 12/11/2024 12/08/2025
Fowler Neal Franklin 1 204,050.00 204,050.00 12/03/2025 12/03/2025
Zoon Kathryn C 5 195,983.54 39,196.71 21/05/2024 15/08/2025
White Marvin L 1 171,015.39 171,015.39 11/11/2024 11/11/2024
Katkin Keith 2 98,834.40 49,417.20 23/05/2025 23/05/2025
Lindahl Richard S 1 10,872.52 10,872.52 21/02/2024 21/02/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
SYNDAX PHARMACEUTICALS, INC. US87164F1057 SNDX

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.